Safety-Quality Latest News news and information

The Indian generic drugmaker Ranbaxy, which already operates under an unprecedented consent decree banning sales of many of its products in the U.S., agreed to plead guilty in federal court and pay $500 million to resolve allegations of shoddy factory inspections and poor quality control.
FULL STORY »

An eight-year initiative aimed at improving healthcare quality and lowering costs has entered its final phase, and its director says the project's lessons could serve as best practices for healthcare providers across the nation.
FULL STORY »

Cancer patients could face high costs for medications under President Barack Obama's healthcare law, industry analysts and advocates warn. Where you live could make a huge difference in what you'll pay.
FULL STORY »

Total spending on prescription drugs declined last year as more Americans filled prescriptions for lower-cost generics and some filled fewer prescriptions in general, according to a new study.
FULL STORY »

Quest Diagnostics Inc. will pay a $70,000 penalty and no longer automatically disqualify job applicants with prior arrests or criminal convictions as part of a settlement agreement with the New York attorney general's office.
FULL STORY »

HHS keeps a list of people who are excluded from giving even indirect care to Medicare patients, and new guidelines urge providers to check their personnel rosters against the list once a month.
FULL STORY »

A new genetic test can help distinguish between aggressive and low-risk forms of prostate cancer, a study suggested, offering a tool that could enable men to delay or forgo surgery.
FULL STORY »

Only half of people in the U.S. who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, health officials said on Tuesday.
FULL STORY »

A project that aims to ease transitions of care and another that seeks to improve quality of life among Latina breast cancer survivors are among 51 research projects in 21 states chosen to receive a total of $88.6 million in funds from the Patient-Centered Outcomes Research Institute.
FULL STORY »

A provision in the U.S. House of Representatives' version of the Patient Protection and Affordable Care Act that was left out of the Senate version has been resurrected and signed into law in the state of Georgia.
FULL STORY »